@misc{indiciae54ca76ba98f0,
  title = {A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic},
  author = {Malimova, M. and Sidhom, E.-H. and Satyam, A. and Dvela-Levitt, M. and Melanson, M. and Chamberlain, B. T. and Alper, S. L. and Santos, J. and Gutierrez, J. and Subramanian, A. and Grinkevich, E. and Bricio, E. R. and Kim, C. and Clark, A. and Watts, A. and Thompson, R. and Marshall, J. and Pablo, J. L. and Coraor, J. and Roignot, J. and Vernon, K. A. and Keller, K. and Campbell, A. and Emani, M. and Racette, M. and Bazua-Valenti, S. and Padovano, V. and Weins, A. and McAdoo, S. P. and Tam, F. W. K. and Ronco, L. and Wagner, F. and Tsokos, G. C. and Shaw, J. L. and Greka, A.},
  year = {2020},
  doi = {10.1101/2020.06.30.180380},
  url = {https://www.biorxiv.org/content/10.1101/2020.06.30.180380v1},
  note = {Source identifier: 10.1101/2020.06.30.180380}
}